CClinicalTrials.gg
CompletedNCT00265161Updated Jun 1, 2007

The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.

An observational study in Influenza Vaccines, sponsored by HaEmek Medical Center, Israel. Completed at 1 site in Israel. Open to participants aged 18 Days and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2007-06-01.

Sponsored by HaEmek Medical Center, Israel · Observational

Study type
Observational
Model
Defined population
Time perspective
Retrospective
Enrollment
40
Ages
18 Days and older
Sex
All
01

Study summary

The study will be held in the winter of 2005-2007. The aim is to assess the effectiveness of the influenza vaccine in health care workers (HCW).

Read the detailed description

The study will be held in the winter of 2005-2006. Groups of vaccinated HCW and not vaccinated HCW will be followed for symptoms suggestive of influenza. For each event a quick through test for influenza A or B will be done and if positive will be confirmed by viral study. Data regarding days of illness, absence from work, therapy etc., will be collected. Effectiveness will be calculated as well as cost/effectiveness of vaccination.

02

Conditions studied

  • Influenza Vaccines

Browse trials for

Keywords

  • influenza vaccine
  • effectiveness
  • health care worker
  • OBSERVATIONAL STUDY
03

In context

Influenza, Human

2,214 studies on the registry are indexed under Influenza, Human; 163 are open to participants now.

This study's enrollment of 40 is below the median of 300 across 305 observational studies indexed under Influenza, Human.

Browse Influenza, Human studies →

Lead sponsor

HaEmek Medical Center, Israel is the lead sponsor of 228 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Days and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Previously healthy health care worker vaccinated or not

Exclusion criteria

Exclusion Criteria:

  • Immunocompromised state
05

Study design

Observational model
Defined population
Time perspective
Retrospective
Enrollment
40 participants
06

Study locations

1 site
  • Pediatric Dpt A', HaEmek Medical Center
    Afula, 18101, Israel
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00265161
Lead sponsor
HaEmek Medical Center, Israel
First posted
Dec 14, 2005
Start date
Dec 2005
Completion
Mar 2007
Last update
Jun 1, 2007

Study contacts

Dan Miron, MD
principal investigator · HaEmek Medicak Center, Afula, Israel

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion